Clinical Trial Detail

NCT ID NCT01628471
Title MTD Determination, Safety and Efficacy of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Uman Pharma
Indications

lung non-small cell carcinoma

Therapies

Decitabine + Genistein

Age Groups: adult

No variant requirements are available.